A B S T R A C T An enzyme which degrades native collagen at neutral pH has been isolated from cultures of rheumatoid synovium in vitro, but little or no collagenolytic activity has been found in homogenates of fresh rheumatoid synovium. Similar to most other mammalian collagenases this synovial enzyme is readily inhibited by serum proteins. Proteins of synovial fluid are derived largely from serum and synovial fluid from noninflamed joints was found to inhibit synovial collagenase; the inhibitor was destroyed by trypsin, but not by hyaluronidase. Inhibitory activity was reduced in approximately one-half of the fluids from patients with rheumatoid arthritis. In a total of nine synovial fluids, collagenolytic activity was detectable. This activity was not present in constant amounts in synovial fluids aspirated at different times from the same patient and tended to vary inversely with the titer of inhibitory proteins. The collagenolytic activity in the synovial fluids from different patients was variably inhibited by serum proteins. Two distinct collagenases were detected in some rheumatoid synovial fluids and separated by gel filtration. One, labeled "B" enzyme, with an estimated molecular weight 20,000-25,000 resembled the collagenase obtained from synovial cultures. The other, labeled "A" enzyme with an estimated molecular weight of 40,000-50,000. was not inhibited by serum. Unlike the leukocytic collagenase, however, the "A" enzyme degraded collagren fibrils as well as collagen in solution. Disc electrophoresis on acrylamide gels and electron microscopy of segment long spacing (SLS) aggregates of reaction products of the enzymes at 27°C demonstrated that both "A" and "B" enzymes cleaved collagen molecules at a point three-quarters from the amino terminal end of the molecule. Thus collagen degradation in rheumatoid arthritis could result from the operation of these two collagenases.
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INTRODUCTION
An enzyme capable of degrading native, undenatured collagen at neutral pH has been detected in the medium from organ cultures of rheumatoid synovium (1) (2) (3) (4) . The properties of this collagenase are similar to those of an enzyme obtained from cultures of normal human skin (5) and to that from cultures of several tissues from the metamorphosing tadpole (6) . Crude and partially purified preparations of these enzymes are readily inhibited by serum proteins. Furthermore, no collagenase has been found in homogenates of these tissues whereas homogenates of human granulocytes have been shown to contain detectable collagenase (7, 8) . In order to establish a role for these tissue collagenases in the remodelling or destruction of collagenous tissues it is necessary to demonstrate that enzyme(s) with similar properties to that released in vitro is produced in vivo at levels sufficient to overcome the inhibition by serum proteins or in a form which is not inhibitable by serum.
Svnovial fluid is formed by the exudation of proteinrich fluid from subsynovial capillaries and by the addition of proteins and proteinpolysaccharides synthesized by the synovial lining cells. It seemed possible that in rheumatoid arthritis, enough collagenase might be released into some synovial fluids from cells such as the synovial cells to be detected despite the presence of the serum proteins. In the present study such collagenolytic activity has been measured in synovial fluids from several patients with rheumatoid arthritis. This activity has been shown to consist of two collagenases of different molecular size and of different susceptibility to inhibition by serum proteins. Collagenase assay (broken line) was performed using 100 /Al samples of selected fractions in the system described in Table I. was approximately 30,000 cpm/mg. Collagen gels were prepared by incubating 50 pul of a 0.05% solution of collagen in 0.1 M Tris-HCI, pH 7.6, 0.005 M CaCi2 at 370C in small plastic tubes. The period of incubation in the assay of selected enzymes and synovial fluids was 2-6 hr at 370C.
METHODS
To terminate the assay, the contents of each tube were centrifuged and aliquot portions of the supernatant solution counted in modified Bray's solution in a Packard Tri-Carb scintillation counter (2) . An excess of trypsin (2 X crystallized, Worthington Biochemical Corp., Freehold, N. J.) was incubated with a collagen gel in each assay to serve as a quality control for the collagen. Viscometry was used to monitor the reaction of enzyme and collagen in solution (approximate concentration of 0.08%). Ostwald viscometers were used with the water bath temperature maintained at 27°+ 0.050C. The viscometric data were expressed as per cent initial specific viscosity (77.,) as a function of time.
Analysis of reaction products. Disc electrophoresis on polyacrylamide gels of the products of reaction of enzyme and collagen in solution at 27°C was performed according to the method of Nagai, Gross, and Piez (9) .
Segment long spacing (SLS) aggregates of tropocollagen (TC) and the products of the reaction with enzyme were produced by the addition of 0.5% salt-free adenosine triphosphate (ATP) to an equal volume of reaction products in 0.05 M acetic acid containing the equivalent of 0.05-0.1% collagen (6) . Specimens for electron microscopy were prepared in the following manner. A drop of sample was placed on a 400-mesh carbon-coated grid and withdrawn nearly to dryness with a strip of lens paper. In similar fashion a drop of ammonium molybdate (1/10 saturated, aqueous) was applied and immediately withdrawn. This procedure, referred to as "negative staining," results in the deposition of an electron-dense glass that surrounds particles of the sample. Grids were examined in a Philips Miscellaneous. The inhibition of synovial collagenase by synovial fluid or serum was assayed by incubation of the substance to be tested with partially purified synovial enzyme. Protein determinations on synovial fluids were per-formed by the biuret method (12) . Hyaluronidase from bovine testis (465 U/mg) was obtained from Calbiochem. Soybean trypsin inhibitor was obtained from Sigma Chemical Co. Crystallized yeast alcohol dehydrogenase and a-chymotrypsin, both used in calibration of a Bio-Gel P-200 column, were assayed by the method of Racker (13) and Kunitz (14) , respectively.
RESULTS
Collagenase activity was found in concentrated culture media from mass cultures of rheumatoid synovium. The enzyme was then partially purified by gel filtration on Sephadex G-200 (Fig. 1) . Fractions containing collagenase activity were pooled, concentrated, and used in subsequent experiments. Synovial fluid aspirated from the knee of a patient with degenerative joint disease and centrifuged at 10,000 g to remove cells and particulate matter inhibited the action of this partially purified synovial collagenase upon reconstituted collagen fibrils at 370C (Table I) . When trypsin was incubated with the synovial fluid before enzyme was added, the inhibitory effect of the normal synovial fluid was abolished. Degradation of hyaluronic acid in the synovial fluid by the action of testicular hyaluronidase did not diminish the inhibition. This preparation of hyaluronidase was shown The assay system was as follows: 50 Ml of solutions of 14C-collagen (0.2%, containing 1200 cpm) were warmed at 370C
to form gels; 50 Ml of partially purified synovial enzyme (E) (approximately 20,g protein) was added to the appropriate tubes; 50 Ml from one of the following mixtures and (or) TrisCaCI2 buffer was then added to bring final volume to 200 ,l. 10 MlI tryspin (1 mg/ml) was incubated at 370C for 30 min with 1.0 ml of synovial fluid (NSF) from a patient with a noninflammatory knee effusion; then 10 Mul soybean tryspin inhibitor (1.0 mg/ml) was added to this mixture to inactivate the tryspin. 10 ,l hyaluronidase (1.0 mg/ml) was incubated with 1.0 ml NSF at 370C. All mixtures plus soybean trypsin inhibitor and NSF alone were then dialyzed against 0.1 M Tris-HCI, pH 7.6, 0.005 M CaCI2 before incubation with "C-collagen gels and enzyme for 4 hr at 370C. When incubated without added collagenase, neither hyaluronidase nor soybean tryspin inhibitor produced collagenolysis. Results of the collagenolytic assay and the leukocyte count (WVBC/mm5) of synovial fluids aspirated from the same knee of a patient with chronic, progressive rheumatoid arthritis on the date noted are shown. All four assays were performed on the same day using the same collagen gels as substrate. Differential leukocyte counts were similar in all fluids (80-87% polymorphonuclear leukocytes). Assay system was as follows: 50 1u1 "4C-collagen (0.2% gels containing 1700 cpm); 100 ,IA synovial fluid; 50 Mul of Tris-CaCl2 buffer; incubation time was 4 hr at 370C. Results are corrected for control gel incubated without enzyme.
to be active by its ability to decrease viscosity of the synovial fluid to that of serum of a similar protein conicentration. Heating the synovial fluid at 560C for 4 hr did not decrease the inhibitory activity. 42 samples of synovial fluid fromIpatients with a variety of disorders were then assayed using the system described in Table  T . Included among these specimens of synovial fluid were 22 from patients with rheumatoid arthritis. Of the 20 synovial fluids from patients other than those with rheumatoid arthritis, 15 inhibited synovial collagenase more than 76%. All seven fluids from patients with traumatic or degenerative arthritis were in this category.
Fluids that showed less than 76% inhibition were from patients with septic arthritis (three of five), gout (one of two), and pseudogout (one of three). In contrast, 13 of the 22 fluids from patients with active rheumatoid arthritis showed inhibition less than 76%. Differences in inhibition could not be correlated with concentration of protein in the fluids. Synovial fluid was aspirated from the same knee of a patient with rheumatoid arthritis on the dates shown. Leukocyte count ranged from 13,000-29,000/mm3 in these fluids. Assay system was that described in Tables I and II. Of particular interest were five other synovial fluid specimens which inhibited synovial enzyme less than 10%. Two of these were from presumed septic joints (cultures negative in a clinical setting consistent with gonococcal arthritis) and three from rheumatoid joints. When samples of these fluids were incubated without added enzyme, significant collagenolytic activity was noted in each specimen. These observations led us to study synovial fluid from individual patients aspirated at intervals of weeks to months to compare the degree of inhibition and (or) collagenase at one phase of disease with another. In Table II are shown the results of such a study in one patient with chronic, seropositive rheumatoid arthritis. The synovial fluid was found to have collagenolytic activity during one 2-wk period. There was no measurable collagenase in fluids aspirated before or after this period.
There was no correlation between synovial fluid leukocyte count and collagenase activity in the many synovial fluids studied. Several fluids with more than 60,000 WBC/mm3 and differential counts of > 90% polymorphonuclear leukocytes were demonstrated to have no significant enzyme activity. Freezing and thawing synovial fluids had no measurable effect upon collagenase activity; once the enzyme had been partially purified, however, the activity diminished rapidly on storage. (Table III) . However, the fluid which had the termination of approximate molecular weights least collagenolytic activity was most inhibitory and s by gel filtration. Open circles represent pro-the fluid which inhibited the least had the highest colr calibration of the column: 1 =alcohol de-lagenolytic activity. There are several possible ways to mol wt 150,000; 2 = bovine serum albumin, interpret these data, among which are the following:
); 3= pepsin, mol wt 35,500; 4a-chymo-) that an easily reversible association existed between wt 22,500; 5 = cytochrome C, mol wt 13,000. (a) ed circle labeled "A" and closed circle "B" synoval fluid inhibitor proteins and collagenase, and that alues for V/Vo obtained for the two colla-in these particular patients there was a decreased conin synovial fluid from the same patient. Half-centration of this inhibitor protein; (b) that a part of "A"' indicates the value V/Vo for the colla-the collagenase present in the synovial fluid was not inthe synovial fluid from another rheumatoid ..
ich there was no enzyme corresponding to hibited by other proteins present in the fluid; and (c) that a combination of (a) and (b) was operative. Fig. 1 . The other was less retarded and presumably of greater molecular weight. Fractions containing these two activities were concentrated with Aquacide and passed through a BioGel P-200 column (112 X 0.9 cm) which had been calibrated using globular proteins of known molecular weight (15) (Fig. 2) . The void volume (Vo) was established using Blue Dextran (Pharmacia Fine Chemicals). V/V0 for the smaller of these two enzymes ("B") was in the range found for partially purified synovial ples of each reaction mixture described in Fig. 3 were subjected to disc electrophoresis on polyacrylamide gels. The control sample contained five times more collagen than did the gels of the reaction products. Definitions for the symbols used are as follows: a = single polypeptide chain; p = a dimer of a-chains, linked covalently; y = three-stranded polypeptide chain; pA and aA = TCA; aB = TCB.
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collagenase and a-chymotrypsin. Its molecular weight was estimated to be 20,000 to 25,000. The other collagenolytic activity ("A") was less retarded and its estimated molecular weight was roughly twice that of collagenase "B."
Four rheumatoid synovial fluids containing collagenolytic activity were found in a separate group of 27 fluids from patients with rheumatoid arthritis. This activity was assayed with and without the addition of pooled normal human serum, using the "C-collagen fibril assay at 37'C as described in Tables I and II . It was found that 10 Al of serum inhibited the total collagenolytic activity in these four fluids by 0%, 37%, 46%, and 24%, whereas 5 1l of serum was sufficient to inhibit the partially purified synovial collagenase more than 80%. These results suggested that the collagenase which was not inhibited by serum probably accounted for most of the total activity in these fluids. The observation that some inhibition resulted from the addition of serum to three of four of these fluids indicated that the enzyme resembling cultured synovial collagenase ("B") accounted for a definite fraction of the total collagenase activity in spite of the presence of other, possibly inhibitory, synovial fluid proteins. The one synovial fluid in which collagenase was not inhibited by proteins was dialyzed and concentrated to 1.0 ml after incubation for 30 min at 37°C with 10 Ag hyaluronidase, and passed over the Bio-Gel P-200 column. Only one peak containing collagenolytic activity was found; the peak is labeled A' in Fig. 2 . As expected, this activity was eluted in a position similar to the enzyme which was not inhibited by serum.
Activities of the two enzymes "A" and "B" were assayed using collagen in solution at 270C with and without added serum and following the reaction viscometrically (Fig. 3) . It can be seen that the activity of "B" with an estimated molecular weight similar to synovial collagenase was markedly inhibited by normal human serum added in a final dilution of 1: 10. The other collagenase activity ("A") was not inhibited significantly by the same concentration of serum. At the end of 24 hr incubation at 270C, the reaction was stopped by the addition of ethylenediaminetetraacetate (EDTA) and the reaction products were subjected to electrophoresis on polyacrylamide gels (Fig. 4) . The band pattern confirmed the viscometric findings: enzyme "A" cleaved the collagen molecule in the presence of serum producing a pattern consistent with TCA and TCB, whereas enzyme "B" was inhibited.
In Table IV Equal amounts of each collagenase preparation were used in both the assay at 370C with '4C-labeled collagen fibrils as substrate and in the assays at 270C with collagen in solution as substrate. Rates for the viscometric assays were determined from the initial slopes of the fall in specific viscosity when plotted as a semilogarithmic function of time of incubation (16) and are expressed in arbitrary units (U/hr) partially purified synovial collagenase obtained from culture of rheumatoid synovium in vitro. Both collagenases ("A" and "B") from synovial fluid and the cultured synovial collagenase produced SLS aggregates consistent with the same site of cleavage of collagen molecules. Moreover, since SLS of both TCA and TCB were identified, the molecules had to be cleaved across the three chains and not digested simply from the B end.
In Figs. 5 and 6 the results of "negative staining" of SLS aggregates are shown. To visualize adequately the TCB SLS it was found necessary to precipitate these fragments with ammonium sulfate and then aggregate the TCB from a relatively homogeneous preparation of these smaller fragments. A great tendency for hybrid forms of SLS to develop was found, particularly in reaction mixtures in which the enzyme had been allowed to take the reaction to completion. Although it was difficult to form individual SLS of TCB large enough to show banding patterns, polymers of TCB SLS were occasionally found (Fig. 6 a) . Fig. 6 b, c, and d show other evidence for the presence of intact TCB. Measurements of the SLS suggest that the enzyme has not cleaved further either the TCB or TCA fragment under these conditions.
DISCUSSION
These data indicate that collagenase is produced and released from cells in vivo in man, and that its production is not demonstrable only by culturing certain epithelial and mesenchymal cells in vitro. With the exception of the collagenase extracted from homogenates of human leukocytes (7, 8) , previous demonstrations of collagenases from vertebrate tissues required that the tissues be cultured in vitro on collagen gels or in enriched media. This has been a requirement for demonstrating and harvesting the rheumatoid synovial collagenase, and has served as an objection to assigning to rheumatoid synovial collagenase a significant role in the destruction of connective tissue accompanying this disease. (8, 18 ) is resistant to serum inhibition, has a higher apparent molecular weight (70,000) than the cultured synovial enzyme, and properties similar to those of synovial fluid collagenase "A." However, one difference between the action of collagenase "A" and the leukocytic collagenase is the ability to digest collagen fibrils at 370C. It is reported that the partially purified leukocytic collagenase is relatively ineffective in degrading reconstituted collagen fibrils when compared with its activity upon collagen in solution (8, 18) . In contrast, enzyme "A" from synovial fluid degrades fibrils and molecules in solution in a ratio similar to that found using partially purified synovial collagenase. In addition, we have found several synovial fluids with white blood cell counts of > 60,000/ mm3 which have negligible collagenolytic activity. 
